Dietary, Lifestyle, and Clinical Predictors of Lipoprotein-associated Phospholipase A2 Activity in Individuals Without Coronary Artery Disease

Overview

Journal Am J Clin Nutr

Publisher Elsevier

Specialty Nutritional Sciences

Date 2010 Jan 29

PMID 20107195

Citations 16

Authors

Ida J Hatoum

Jeanenne J Nelson

Nancy R Cook

Frank B Hu

Eric B Rimm

Affiliations

Soon will be listed here.

Abstract

Background: Elevated lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) may be positively associated with risk of coronary artery disease, yet little is known about potentially modifiable factors related to Lp-PLA(2).

Objective: The aim of this study was to determine dietary, lifestyle, and clinical measures associated with Lp-PLA(2) activity.

Design: We measured Lp-PLA(2) activity in 853 female participants of the Nurses' Health Study and 878 male participants of the Health Professionals Follow-Up Study who were free of cancer and cardiovascular disease. Multivariable linear regression models were used to assess the relation between potentially modifiable factors and Lp-PLA(2).

Results: The replacement of 5% of energy from carbohydrates with energy from protein was associated with 2.2 nmol . min(-1) . mL(-1) lower levels of Lp-PLA(2) (95% CI: -3.1, -0.4) activity, and every 15-g/d increase in alcohol consumption was associated with 4.4 nmol . min(-1) . mL(-1) lower levels of Lp-PLA(2) activity (95% CI: -6.4, -2.4). Smoking (beta = 10.2; 95% CI: 4.8, 15.5), being overweight (beta = 7.5; 95% CI: 3.6, 11.3), aspirin use (beta = 6.0; 95% CI: 2.1, 10.0), hypercholesterolemia (beta = 15.0; 95% CI: 11.3, 18.8), and age (beta = 2.5; 95% CI: 1.34, 3.74) were associated with elevated Lp-PLA(2) activity, whereas postmenopausal hormone use (beta = -15.8; 95% CI: -19.4, -12.1) and cholesterol medication use (beta = -9.6; 95% CI: -18.2, -1.1) were inversely associated.

Conclusion: We found that not smoking, use of postmenopausal hormones, having a body mass index (in kg/m(2)) < or =25, increased alcohol consumption, and increased protein consumption all represent potential modifiable factors that may favorably influence Lp-PLA(2) activity.

Citing Articles

Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Wilkens T, Tranaes K, Eriksen J, Dragsted L Nutr Rev. 2021; 80(5):1311-1339.

PMID: 34957513 PMC: 9308455. DOI: 10.1093/nutrit/nuab102.

The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review.

English C, Mayr H, Lohning A, Reidlinger D Nutr Rev. 2021; 80(6):1371-1391.

PMID: 34651191 PMC: 9086773. DOI: 10.1093/nutrit/nuab051.

The relationship between dietary patterns and lipoprotein-associated phospholipase A2 levels in adults with cardiovascular risk factors: Tehran Lipid and Glucose Study.

Seyedi S, Mottaghi A, Mirmiran P, Hedayati M, Azizi F J Res Med Sci. 2020; 25:3.

PMID: 32055243 PMC: 7003539. DOI: 10.4103/jrms.JRMS_256_19.

Replacing carbohydrate with protein and fat in prediabetes or type-2 diabetes: greater effect on metabolites in PBMC than plasma.

Kim M, Song G, Kang M, Yoo H, Jeong T, Lee S Nutr Metab (Lond). 2016; 13:3.

PMID: 26788114 PMC: 4717650. DOI: 10.1186/s12986-016-0063-4.

Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy.

Paik J, Kim M, Kim M, Yen Y, Ahn H, Lee S Age (Dordr). 2015; 37(2):32.

PMID: 25840804 PMC: 4385327. DOI: 10.1007/s11357-015-9770-4.

References

Yokode M, Kita T, Arai H, Kawai C, Narumiya S, Fujiwara M . Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci U S A. 1988; 85(7):2344-8. PMC: 279988. DOI: 10.1073/pnas.85.7.2344. View

Packard C, OReilly D, Caslake M, McMahon A, Ford I, Cooney J . Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000; 343(16):1148-55. DOI: 10.1056/NEJM200010193431603. View

Rimm E, Williams P, Fosher K, Criqui M, Stampfer M . Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319(7224):1523-8. PMC: 28294. DOI: 10.1136/bmj.319.7224.1523. View

Iribarren C, Gross M, Darbinian J, Jacobs Jr D, Sidney S, Loria C . Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study. Arterioscler Thromb Vasc Biol. 2004; 25(1):216-21. DOI: 10.1161/01.ATV.0000148322.89911.44. View

Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C . Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern.... Circulation. 2004; 110(14):1903-8. DOI: 10.1161/01.CIR.0000143377.53389.C8. View

Wassertheil-Smoller S, Kooperberg C, McGinn A, Kaplan R, Hsia J, Hendrix S . Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women. Hypertension. 2008; 51(4):1115-22. DOI: 10.1161/HYPERTENSIONAHA.107.103721. View

Shi Y, Zhang P, Zhang L, Osman H, Mohler 3rd E, Macphee C . Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses. Atherosclerosis. 2006; 191(1):54-62. DOI: 10.1016/j.atherosclerosis.2006.05.001. View

Mukamal K, Jensen M, Gronbaek M, Stampfer M, Manson J, Pischon T . Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation. 2005; 112(10):1406-13. DOI: 10.1161/CIRCULATIONAHA.105.537704. View

Sabatine M, Morrow D, ODonoghue M, Jablonksi K, Rice M, Solomon S . Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2007; 27(11):2463-9. DOI: 10.1161/ATVBAHA.107.151670. View

10.

Khuseyinova N, Imhof A, Rothenbacher D, Trischler G, Kuelb S, Scharnagl H . Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis. Atherosclerosis. 2005; 182(1):181-8. DOI: 10.1016/j.atherosclerosis.2004.10.046. View

11.

Tzotzas T, Filippatos T, Triantos A, Bruckert E, Tselepis A, Kiortsis D . Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women. Nutr Metab Cardiovasc Dis. 2007; 18(7):477-82. DOI: 10.1016/j.numecd.2007.04.004. View

12.

Pedersen M, Koenig W, Christensen J, Schmidt E . The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults. Eur J Nutr. 2008; 48(1):1-5. DOI: 10.1007/s00394-008-0758-z. View

13.

Giovannucci E, Liu Y, Hollis B, Rimm E . 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168(11):1174-80. PMC: 3719391. DOI: 10.1001/archinte.168.11.1174. View

14.

Caslake M, Packard C . Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Curr Opin Lipidol. 2003; 14(4):347-52. DOI: 10.1097/00041433-200308000-00002. View

15.

Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H . Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 1996; 93(7):1346-53. DOI: 10.1161/01.cir.93.7.1346. View

16.

Craig W, Palomaki G, Haddow J . Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989; 298(6676):784-8. PMC: 1836079. DOI: 10.1136/bmj.298.6676.784. View

17.

Zhang S, Shibata H, Karino K, Wang B, Kobayashi S, Masuda J . Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population. Hypertens Res. 2007; 30(5):403-9. DOI: 10.1291/hypres.30.403. View

18.

Robins S, Collins D, Nelson J, Bloomfield H, Asztalos B . Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol. 2008; 28(6):1172-8. DOI: 10.1161/ATVBAHA.107.160739. View

19.

El-Saed A, Sekikawa A, Zaky R, Kadowaki T, Takamiya T, Okamura T . Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men. J Epidemiol. 2007; 17(6):179-85. PMC: 3659786. DOI: 10.2188/jea.17.179. View

20.

Cassidy A, Chiuve S, Manson J, Rexrode K, Girman C, Rimm E . Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. Arterioscler Thromb Vasc Biol. 2008; 29(1):134-9. PMC: 3789235. DOI: 10.1161/ATVBAHA.108.171066. View